Back to Trades
Sharp John P
Chief Financial OfficerCIK 0001342894
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 1
- Buy transactions
- 0
- Sell transactions
- 0
- Companies
- 1
- Active
- 2026
Across 1 filing between 2026, Sharp John P, Chief Financial Officer, has disclosed $0 in transactions — all concentrated in Skye Bioscience, Inc. (SKYE). Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
1 loaded
| Apr 28 | SKYE Skye Bioscience, Inc. | Sharp John P | Chief Financial Officer | Other | $0 |
1 filing